post-bg-515
calendary December 13, 2023

Import substitution: new domestic drugs for the treatment of type 2 diabetes are entering the market

In the summer of 2023, it became known about the purchase by Novo Nordisk of the Canadian company Inversago Pharma, which is studying methods of treating people with obesity, diabetes and metabolic disorders using drugs based on glutides. At the same time, Novo Nordisk in Russia already has 3 registration certificates for drugs containing liraglutide. Russian companies are also showing interest in this group of substances.

In September 2023, PROMOMED RUS received a registration certificate for the drug Enligria, which includes liraglutide. The drug is available in the form of a solution for subcutaneous administration in 3 ml cartridges for installation in a reusable syringe pen. The drug Enligria is intended for the correction of excess body weight in adults and adolescents over the age of 12 years as part of an integrated approach. Enligria is not a replacement for insulin.

Liraglutide as part of the drug has a long half-life (13 hours), which allows the drug to be used once a day.

The PROMOMED RUS company plans to supply the drug to pharmacies in October this year. At the same time, the company has two more drugs based on glutides at the registration stage.

The full production cycle of the drug is carried out at the production sites of Biokhimik JSC or Zavod Medsinez LLC. The manufacturer of the substance is JSC Biokhimik.

According to Promomed Group of Companies, the release of Russian GLP agonists will eliminate the shortage of similar drugs that arose in 2022, associated with the cessation of supplies from the only manufacturer.

It is worth noting that the Promomed Group of Companies portfolio includes other drugs intended for weight loss and the treatment of concomitant diseases. Among them is the well-known in Russia line of drugs Reduxin based on sibutramine.

Sibutramine is a prodrug, the metabolites of which increase the feeling of satiety and reduce the need for food, as well as increase thermal production.

References:
  1. https://pharmvestnik.ru/content/news/Promomed-vyvodit-na-rynok-importozameshaushii-preparat-dlya-terapii-saharnogo-diabeta.html
  2. https://grls.minzdrav.gov.ru/Grls_View_v2.aspx?routingGuid=d76a8f41-c5cc-4215-af60-8b5953edda2c

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE